))
Venturing into Longevity: Insights from Co-Founder and General Partner at Apollo Health Ventures, Ole Mensching, Ph. D., EN (#11)
Manage episode 416951898 series 3572985
Philipp Hemmersbach에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Philipp Hemmersbach 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
In this week's episode we are excited to welcome Ole Mensching, Ph. D., Co-Founder and General Partner at Apollo Health Ventures.
Apollo Health Ventures is a transatlantic early-stage Venture Capital firm specialising in co-founding and investing in healthcare companies targeting age-related diseases. They actively participate in founding ventures, alongside investing in best-in-class external opportunities.
This discussion explores the synergy between science and venture capital, emphasising the role of artificial intelligence in longevity. Apollo Health Ventures' distinct investment approach, combining active co-founding and external opportunities, is highlighted. Key factors like investment periods and ticket size are discussed for their impact on venture success, considering the delicate balance between risk and returns in longevity investing. The conversation concludes with an outlook on the future of longevity and the venture capital market, providing insights into the evolving landscape of healthcare innovation and investment.
23 에피소드
공유
